bg Flashcards
Nigrostriatal pathway
control of movement
affected in parkinson’s disease
Substantia nigra pars compacta > striatum
Describe cortical input to the basal ganglia
Cortical inputs are excitatory (glutamate) for the medium spiny neurons in the striatum.
GPi, Substantia nigra pars reticulata are the same nucleus. The neurons are inhibitory (Gabaergic)
Describe the circuit from GPI to motor output
GPi is inhibitory, it will release GABA onto the VA/VL of the thalamus
The thalamus is excitatory onto the primary motor cortex
Motor output.
Subthalamus is activated, what does it do to the pathway?
Subthalamic nucleus excites GPi, causing inhibition of the cortex (and movement)
Lesions of the subthalamic nucleus produce too much movement (contralateral hemiballismus)
What is the “Direct Pathway”
Cortex excites Striatum
Striatum increases inhibition of Gpi.
Disinhibition: Gpi decreases inhibition on thalamus
Thalamus increases excitatory output to primary motor cortex
Increased output
What is the indirect pathway
Cortex releases excitatory input to striatum
Striatum is inhibitory for GPe! (inhibitory)
GPe decreases inhibition of subthalamic.
Subthalamic is more excitatory for GPi.
GPi increases inhibition of thalamus.
Thalamus decreases stimulation of motor cortex, decreases output.
How does SNpc influence the direct?
Dopamine activates DA1 receptors on the striatum.
Striatum increases inhibitory output to Gpi, thereby increasing motor output.
How does SNpc affect the indirect pathway
Dopamine activates DA2 receptors on the striatum.
This time it is inhibitory, so the striatum decreases inhibition of GPe.
GPe increases inhibition of the subthalamic
Subthalamic decreases stimulation of the Gpi
GPi decreases inhibition on the thalamus, increasing excitation of the cortex, increasing motor output.
What is the role of ACh in striatum?
It will increase striatal output for both pathways.
However it will preferentially increase striatal output into the indirect pathway, increase inhibition of GPe.
This is why anticholinergics are used for parkinsons disorder
Hemiballismus
Chorea
Athetosis
Hemiballismus:
• Spontaneous, involuntary movements
• Usually caused by lacunar infarcts in the subthalamic nucleus
Chorea:
• Nearly continuous rapid movements of face, tongue, or limbs.
• Most common in Huntington’s disease.
Athetosis:
• Slow, writhing movements, mostly in hands and fingers. Patients
cannot maintain a fixed position. Often in children with cerebral
hypoxia, affecting the basal ganglia.
(somewhere between chorea and posture instability)
Hypokinesia
Rigidity
Hypokinesia – decreased amplitude of movements
Rigidity - described as “waxy” or “lead-pipe.”
May be “cogwheeling,” with regular interruptions.
Unlike spasticity, rigidity will resist the whole range of movement, and maybe push back at you.
Dystonia
Dystonia \_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_ Slower than chorea, sustained contractions in twisting postures -Triggered by voluntary movements -Writer’s cramp is most common
Most cases are familial A causes:
• Genetic
• Focal lesions of basal ganglia
• Disorders of dopamine metabolism
Treatment:
• Botulinum toxin
• DBStimulation of the GP
Tardive dyskinesia
abnormality or impairment of voluntary movement:
resulting from drugs that have dopaminergic actions
- antipsychotic drugs (traditional>atypical)
- anti-emetic drugs
- manganese
- these drugs decrease dopamine, this can lead to an upregulation of dopamine receptors and too much sensitivity to dopamine.
Can persist after discontinuation of drugs. Less of a problem with new anti-psychotics
Parkinsons tremor vs Essential tremor
Parkinsons tremor:
(4-6 Hz at rest)
Hands and arms are more common, legs and mouth can also be affected -Begins unilaterally -At rest -BG \_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_
Essential tremor:
(6-8 Hz)
Hands, arms, head, face, legs, trunk Usually bilateral Increases with activity or posture -no other motor abnormalities. -Cerebellum
Huntington Chorea
Autosomal dominant neurodegenerative disorder with cell loss in caudate and putamen
Also affects the cortex (mainly frontal and temporal)
Enkephalin-containing GABAergic cells affected in HD
> more inhibition of STN and increased movement.
Onset 40s and 50s. Progressive and neurodegenerative. Eventually leads to akinetic/rigid form of the disease
Median survival is 15 yrs due to respiratory complications.
Treatment: drugs that decrease dopamine
Major symptoms:
- Chorea
- Dementia
Psychiatric manifestations
- anxiety
- mood changes
- OCD
- impulsiveness
- cognitive impairment
- memory loss